The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation - PubMed (original) (raw)
. 1996 Aug 9;271(32):19084-92.
doi: 10.1074/jbc.271.32.19084.
Affiliations
- PMID: 8702581
- DOI: 10.1074/jbc.271.32.19084
Free article
The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation
F S Monteclaro et al. J Biol Chem. 1996.
Free article
Abstract
The chemoattractant cytokines, MCP-1 (monocyte chemoattractant protein) and MIP-1alpha (macrophage inflammatory protein), are recognized by highly homologous but distinct receptors. To identify receptor domains involved in determining ligand specificity, we created a series of chimeric MCP-1 and RANTES (regulated on activation, normal T cell expressed and secreted)/MIP-1alpha receptors that progressively interchanged the amino terminus and each of the three extracellular loops. Radiolabeled MCP-1 bound with high affinity to the wild-type MCP-1 receptor, but not to the RANTES/MIP-1alpha receptor (C-C CKR-1). Chimeras that retained the amino-terminal extension of the MCP-1 receptor bound MCP-1 with high affinity. In contrast, chimeric MCP-1 receptors, in which the wild-type amino terminus was replaced with the corresponding portion of the RANTES/MIP-1alpha receptor, bound MCP-1 with low affinity. These data indicate that the amino terminus of the MCP-1 receptor is necessary for high affinity binding of the ligand. Very different results were obtained using the RANTES/MIP-1alpha receptor. Radiolabeled MIP-1alpha bound with high affinity to chimeras that expressed the extracellular loops of the RANTES/MIP-1alpha receptor. In contrast to the MCP-1 receptor, substitution of the wild-type amino-terminal extension had little or no effect on MIP-1alpha binding. For the MCP-1, but not the RANTES/MIP-1alpha receptor, the presence of the wild-type amino terminus also significantly lowered the ligand concentration required for maximal signaling. We conclude that the amino-terminal extension of the MCP-1 receptor, but not the RANTES/MIP-1alpha receptor, is critically involved in ligand binding and signal transduction. These data reveal significant functional differences between the two C-C chemokine receptors and suggest a two-step mechanism for activation of the MCP-1 receptor.
Similar articles
- The second extracellular loop of CCR5 is the major determinant of ligand specificity.
Samson M, LaRosa G, Libert F, Paindavoine P, Detheux M, Vassart G, Parmentier M. Samson M, et al. J Biol Chem. 1997 Oct 3;272(40):24934-41. doi: 10.1074/jbc.272.40.24934. J Biol Chem. 1997. PMID: 9312096 - The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
Blanpain C, Doranz BJ, Bondue A, Govaerts C, De Leener A, Vassart G, Doms RW, Proudfoot A, Parmentier M. Blanpain C, et al. J Biol Chem. 2003 Feb 14;278(7):5179-87. doi: 10.1074/jbc.M205684200. Epub 2002 Dec 3. J Biol Chem. 2003. PMID: 12466283 - Role of MCP-1/CCR2 axis in renal fibrosis: Mechanisms and therapeutic targeting.
He S, Yao L, Li J. He S, et al. Medicine (Baltimore). 2023 Oct 20;102(42):e35613. doi: 10.1097/MD.0000000000035613. Medicine (Baltimore). 2023. PMID: 37861543 Free PMC article. Review. - Novel pathways for negative regulation of inflammatory cytokines centered on receptor expression.
Mantovani A, Garlanda C. Mantovani A, et al. Dev Biol Stand. 1999;97:97-104. Dev Biol Stand. 1999. PMID: 10463535 Review. No abstract available.
Cited by
- Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss in sauropsids.
Salve BG, Sharma S, Vijay N. Salve BG, et al. Immunogenetics. 2024 Dec;76(5-6):397-415. doi: 10.1007/s00251-024-01357-5. Epub 2024 Oct 14. Immunogenetics. 2024. PMID: 39400711 - C-C Motif Chemokine Ligand 2 and Chemokine Receptor 2 in Cardiovascular and Neural Aging and Aging-Related Diseases.
Guo D, Zhu W, Qiu H. Guo D, et al. Int J Mol Sci. 2024 Aug 13;25(16):8794. doi: 10.3390/ijms25168794. Int J Mol Sci. 2024. PMID: 39201480 Free PMC article. Review. - Assessing Protein-Protein Docking Protocols: Case Studies of G-Protein-Coupled Receptor Interactions.
Sonawani A, Naglekar A, Kharche S, Sengupta D. Sonawani A, et al. Methods Mol Biol. 2024;2780:257-280. doi: 10.1007/978-1-0716-3985-6_13. Methods Mol Biol. 2024. PMID: 38987472 - Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8.
Sun D, Sun Y, Janezic E, Zhou T, Johnson M, Azumaya C, Noreng S, Chiu C, Seki A, Arenzana TL, Nicoludis JM, Shi Y, Wang B, Ho H, Joshi P, Tam C, Payandeh J, Comps-Agrar L, Wang J, Rutz S, Koerber JT, Masureel M. Sun D, et al. Nat Commun. 2023 Dec 1;14(1):7940. doi: 10.1038/s41467-023-43601-8. Nat Commun. 2023. PMID: 38040762 Free PMC article. - Discovery and characterization of a functional scFv for CCR2 inhibition via an extracellular loop.
Jasiewicz NE, Brown AD, Deci M, Matysiak S, Earp HS, Nguyen J. Jasiewicz NE, et al. Int J Pharm. 2023 Feb 5;632:122547. doi: 10.1016/j.ijpharm.2022.122547. Epub 2022 Dec 24. Int J Pharm. 2023. PMID: 36572264 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous